NHS to pilot 'potentially revolutionary' cancer blood test

Developed by GRAIL

Adam Saville
clock
NHS to pilot 'potentially revolutionary' cancer blood test

The 'Galleri blood test' aims to detect cancers early by looking for abnormal DNA

The NHS is to trial a ‘potentially revolutionary' blood test that could discover a range of different cancer types is to be trialled by the NHS, the national health service's chief executive Sir Simon Stevens has announced. Known as the Galleri blood test, it has been developed by the company GRAIL to spot early signs of cancer by seeking out abnormal DNA shed from cells into the blood. DNA from cancer cells often have differences in the chemical tags compared to DNA from healthy cells. ...

To continue reading this article...

Join Cover

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around Covid-19, regulation, diversity and mental health.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on uncategorised

COVER parent company acquired by Arc

COVER parent company acquired by Arc

Backed by Eagle Tree Capital

COVER
clock 06 April 2022 • 1 min read
National insurance hike to fund social care faces accusations of 'intergenerational raid'

National insurance hike to fund social care faces accusations of 'intergenerational raid'

NICs could be raised 1 percentage point

Hannah Godfrey
clock 20 July 2021 • 2 min read
Unions urge govt to reset approach to LGBT rights

Unions urge govt to reset approach to LGBT rights

Government recently scrapped LGBT Action Plan and disbanded advisory panel

Jon Yarker
clock 19 July 2021 • 1 min read